+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • September 2024
  • 1400 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • August 2024
  • 500 Pages
  • Global
From
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • September 2024
  • 1250 Pages
  • Global
From
Liposomal Products Market 2024-2028 - Product Thumbnail Image

Liposomal Products Market 2024-2028

  • Report
  • May 2024
  • 173 Pages
  • Global
From
Drug Discovery Market by Drug Type, Technology, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Thumbnail Image

Drug Discovery Market by Drug Type, Technology, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • October 2024
  • 197 Pages
  • Global
From
Non-alcoholic Steatohepatitis Biomarker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Non-alcoholic Steatohepatitis Biomarker Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 103 Pages
  • Global
From
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • September 2023
  • 182 Pages
  • Global
From
PPAR-Beta / Delta Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

PPAR-Beta / Delta Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Genfit SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Genfit SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Loading Indicator